Siddhartha Mukherjee, AP Images

Sid Mukher­jee's Vor taps a CAR-T de­vel­op­ment part­ner to strap to its at­tempt at bet­ter stem cell trans­plants

In the buzzy world of on­col­o­gy, few names shine brighter than Co­lum­bia on­col­o­gist and best­selling au­thor Sid­dhartha Mukher­jee, whose Vor Bio­phar­ma is look­ing to rewrite …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.